The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate Biopsies

<i>Background and Objectives</i>: Magnetic resonance imaging (MRI) and the Prostate Imaging-Reporting and Data System (PI-RADS) have become essential tools for prostate cancer evaluation. We evaluated the ability of PI-RADS scores in identifying significant prostate cancer, which would h...

Full description

Bibliographic Details
Main Authors: Dong-Soo Kim, Sung-Kyoung Moon, Joo-Won Lim, Seung-Hyun Jeon, Sang-Hyub Lee
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/57/5/413
_version_ 1827694194972426240
author Dong-Soo Kim
Sung-Kyoung Moon
Joo-Won Lim
Seung-Hyun Jeon
Sang-Hyub Lee
author_facet Dong-Soo Kim
Sung-Kyoung Moon
Joo-Won Lim
Seung-Hyun Jeon
Sang-Hyub Lee
author_sort Dong-Soo Kim
collection DOAJ
description <i>Background and Objectives</i>: Magnetic resonance imaging (MRI) and the Prostate Imaging-Reporting and Data System (PI-RADS) have become essential tools for prostate cancer evaluation. We evaluated the ability of PI-RADS scores in identifying significant prostate cancer, which would help avoid unnecessary prostate biopsies. <i>Materials and Methods</i>: Patients with prostate-specific antigen (PSA) levels ≤ 20 ng/mL, who underwent prostate MRI for evaluation from January 2018 to November 2019, were analyzed. Among them, 105 patients who received transrectal ultrasonography (TRUS)-guided biopsy were included. PSA, PI-RADS scores (low 1–2, high 3–5), biopsy results, and Gleason scores (GS) were evaluated. Biopsies with GS higher than 3 + 4 were considered as significant cancers and biopsies with no cancer or Gleason 3 + 3 were considered insignificant or no cancers. <i>Results</i>: Among the 105 patients, 45 patients had low PI-RADS and 60 had high PI-RADS scores. There were no patients with significant prostate cancer in the low PI-RADS groups. For the high PI-RADS group, 28 (46.7%) patients had significant cancer and 32 (53.3%) had insignificant or no cancer. The sensitivity and specificity of high PI-RADS to detect significant cancer was 100% and 58.4%, respectively. Positive predictive value was 46.7% and negative predictive value was 100%. <i>Conclusions</i>: Low PI-RADS scores on MRI did not show significant prostate cancer and surveillance should be considered in selected cases to prevent unnecessary invasive procedures and overdiagnosis.
first_indexed 2024-03-10T12:00:45Z
format Article
id doaj.art-484961cc188e48dd9468d7ed79c7d79b
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-10T12:00:45Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-484961cc188e48dd9468d7ed79c7d79b2023-11-21T16:59:13ZengMDPI AGMedicina1010-660X1648-91442021-04-0157541310.3390/medicina57050413The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate BiopsiesDong-Soo Kim0Sung-Kyoung Moon1Joo-Won Lim2Seung-Hyun Jeon3Sang-Hyub Lee4Department of Urology, Kyung Hee University School of Medicine, Seoul 02453, KoreaDepartment of Radiology, Kyung Hee University School of Medicine, Seoul 02453, KoreaDepartment of Radiology, Kyung Hee University School of Medicine, Seoul 02453, KoreaDepartment of Urology, Kyung Hee University School of Medicine, Seoul 02453, KoreaDepartment of Urology, Kyung Hee University School of Medicine, Seoul 02453, Korea<i>Background and Objectives</i>: Magnetic resonance imaging (MRI) and the Prostate Imaging-Reporting and Data System (PI-RADS) have become essential tools for prostate cancer evaluation. We evaluated the ability of PI-RADS scores in identifying significant prostate cancer, which would help avoid unnecessary prostate biopsies. <i>Materials and Methods</i>: Patients with prostate-specific antigen (PSA) levels ≤ 20 ng/mL, who underwent prostate MRI for evaluation from January 2018 to November 2019, were analyzed. Among them, 105 patients who received transrectal ultrasonography (TRUS)-guided biopsy were included. PSA, PI-RADS scores (low 1–2, high 3–5), biopsy results, and Gleason scores (GS) were evaluated. Biopsies with GS higher than 3 + 4 were considered as significant cancers and biopsies with no cancer or Gleason 3 + 3 were considered insignificant or no cancers. <i>Results</i>: Among the 105 patients, 45 patients had low PI-RADS and 60 had high PI-RADS scores. There were no patients with significant prostate cancer in the low PI-RADS groups. For the high PI-RADS group, 28 (46.7%) patients had significant cancer and 32 (53.3%) had insignificant or no cancer. The sensitivity and specificity of high PI-RADS to detect significant cancer was 100% and 58.4%, respectively. Positive predictive value was 46.7% and negative predictive value was 100%. <i>Conclusions</i>: Low PI-RADS scores on MRI did not show significant prostate cancer and surveillance should be considered in selected cases to prevent unnecessary invasive procedures and overdiagnosis.https://www.mdpi.com/1648-9144/57/5/413prostate cancermultiparametric magnetic resonance imagingimage-guided biopsyprostate specific antigencancer screening
spellingShingle Dong-Soo Kim
Sung-Kyoung Moon
Joo-Won Lim
Seung-Hyun Jeon
Sang-Hyub Lee
The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate Biopsies
Medicina
prostate cancer
multiparametric magnetic resonance imaging
image-guided biopsy
prostate specific antigen
cancer screening
title The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate Biopsies
title_full The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate Biopsies
title_fullStr The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate Biopsies
title_full_unstemmed The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate Biopsies
title_short The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate Biopsies
title_sort value of low prostate imaging reporting and data system pi rads scores in preventing unnecessary prostate biopsies
topic prostate cancer
multiparametric magnetic resonance imaging
image-guided biopsy
prostate specific antigen
cancer screening
url https://www.mdpi.com/1648-9144/57/5/413
work_keys_str_mv AT dongsookim thevalueoflowprostateimagingreportinganddatasystempiradsscoresinpreventingunnecessaryprostatebiopsies
AT sungkyoungmoon thevalueoflowprostateimagingreportinganddatasystempiradsscoresinpreventingunnecessaryprostatebiopsies
AT joowonlim thevalueoflowprostateimagingreportinganddatasystempiradsscoresinpreventingunnecessaryprostatebiopsies
AT seunghyunjeon thevalueoflowprostateimagingreportinganddatasystempiradsscoresinpreventingunnecessaryprostatebiopsies
AT sanghyublee thevalueoflowprostateimagingreportinganddatasystempiradsscoresinpreventingunnecessaryprostatebiopsies
AT dongsookim valueoflowprostateimagingreportinganddatasystempiradsscoresinpreventingunnecessaryprostatebiopsies
AT sungkyoungmoon valueoflowprostateimagingreportinganddatasystempiradsscoresinpreventingunnecessaryprostatebiopsies
AT joowonlim valueoflowprostateimagingreportinganddatasystempiradsscoresinpreventingunnecessaryprostatebiopsies
AT seunghyunjeon valueoflowprostateimagingreportinganddatasystempiradsscoresinpreventingunnecessaryprostatebiopsies
AT sanghyublee valueoflowprostateimagingreportinganddatasystempiradsscoresinpreventingunnecessaryprostatebiopsies